Patent ID: 9622977
Date: 2017-04-18
CPC Classifications: A61K,A61P

Claim:
1. A controlled release tablet containing no solubilizer, wherein the controlled release tablet is capable of releasing the pharmaceutically active agent at a rate of between 80-100% in 12 hours in a first order rate of release in a USP type 2 dissolution test, the tablet comprising, for every 1000 mg of the dosage form, Acyclovir in an amount of 763.37 mg, a high molecular weight polymer of acrylic acid crosslinked with allyl ethers of pentaerythritol in an amount of 75 mg, Polyethylene oxide in an amount of 25 mg, microcrystalline cellulose in amount 93.83 mg, polyvinylpyrrolidone having a viscosity of 44000-54000 cps in an amount of 30 mg, Magnesium stearate in an amount of 7.5 mg, and Colloidal silicon dioxide 5.0 mg.